Noelle Cloven

Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer

Robert L. Coleman, Gini F. Fleming, Mark F. Brady et al. · New England Journal of Medicine · 2019 · 929 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial

Kathleen N. Moore, Angeles Alvarez Secord, Melissa A. Geller et al. · The Lancet Oncology · 2019 · 537 citations

Medicine, Oncology, Pharmacotherapy +10

Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial

Domenica Lorusso, Yang Xiang, Kosei Hasegawa et al. · The Lancet · 2024 · 349 citations

Medicine, Oncology, Pharmacotherapy +13

Management of Ovarian Cancer in Patients Older Than 80 Years of Age

Noelle Cloven, Alberto Manetta, Michael L. Berman et al. · Gynecologic Oncology · 1999 · 83 citations

Medicine, Gynecology, Oncology +14

Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer

Ignace Vergote, José Alejandro Pérez Fidalgo, Erika Hamilton et al. · Journal of Clinical Oncology · 2023 · 71 citations · Full text

Medicine, Oncology, Pharmacology +15